Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Thumbnail

What is the radiologist's role in variations of prostate cancer detection?

Prior studies have focused on radiologist performance rather than patient outcomes, leaving the topic of variable diagnoses and what factors impact them—race, ethnicity, age, biopsy type, etc.—open for debate. 

Thumbnail

PET/CT findings predict post-treatment, radiation-induced hypothyroidism

Radiation-induced hypothyroidism is common yet underdiagnosed, potentially owing to a lack of follow-up consensus in patients treated with radiation therapy for head and neck cancers.

Radiologists are overlooking signs of pancreatic cancer on imaging more and more, new study indicates

The research revealed that 7.7% of patients screened for pancreatic cancer had their tumors missed on initial imaging exams but were diagnosed with cancer between three and 18 months later.  

Thumbnail

Prostate cancer detection boosted with computer assistance

The addition of computer-aided diagnostic generated MRI series could help radiologists identify clinically significant prostate cancer more frequently. 

Thumbnail

Prostate cancer patients who undergo surveillance MRI in lieu of yearly biopsy not at increased risk

Results of the new work indicate that risks are not exacerbated when imaging is the chosen method of surveillance up until the three-year mark, suggesting that patients can safely forego invasive biopsy for a limited period. 

Thumbnail

Current LDCT eligibility criteria leave women and minorities behind

Compared to USPSTF 2013,  modified eligibility criteria could increase cancer detection by 37%.

Radiomics-based models can detect pancreatic cancer well before clinical diagnosis

Recently a radiomics-based machine learning model proved highly accurate at predicting which patients would develop pancreatic cancer three to 36 months after abdominal CT imaging.

black woman breast cancer pink ribbon

Disparities in breast cancer detection and care persist, despite a drop in mortality, new ACS report reveals

While Black women have lower incidence of breast cancer diagnosis, their mortality rates are 40% higher than those observed in white women.  

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup